Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for maintenance of anesthesia in adult cardiac surgery
IRCT20240624062233N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine in cardiac morbidity (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Hemodynamic responses, Inflammatory factors and 2 more. Started Jun 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on IRCT20240624062233N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240624062233N1.